Delivery Order SPE2DB25D3012-SPE2DB25FWZSC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,706.37 delivery order for Glycopyrrolate 1 mg/5 ml vials on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed-price contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Glycopyrrolate 4 mg/20 ml vials with a ceiling value of $1,083.71. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Glycopyrrolate 0.2 mg/mL in 5 mL vials, with a ceiling value of $14,491.55 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $367,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.4 mg/2 ml vials of glycopyrrolate. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564246806 - GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML. The contract has a ceiling value of $2,349.10 and a completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,802.34 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 mL vials on August 15, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. Glycopyrrolate is an anticholinergic medication used in military and federal healthcare settings for various therapeutic applications,...
- The Defense Logistics Agency Troop Support Medical awarded a $3,734.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561531690 Glycopyrrolate 4 mg/20 ml vials. The delivery order is for 20 ml vials of the medication to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance required from July 18-19, 2023. As a key medical supplier to the Department of Defense, the Defense Logistics Agency Troop Support Medical utilizes contracts...
- This is a $3,782.55 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen is a key supplier of a wide range of medical commodities, including prescription medications, vaccines, and medical supplies, to various federal agencies and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4561569140! GLYCOPYRROLATE INJECT. The $6,416.43 contract has a performance period through July 21, 2023 and was not set aside for any particular business type. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from their corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a $1,475.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GLYCOPYRROLATE INJECT. The contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not set aside for any particular business type....
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZSCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,955.44 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 mL vials (5 mL units). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 3, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement extending through December 2026 that supports the global pharmaceutical supply requirements for military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare organizations, maintaining a substantial portfolio of brand-name and generic medications, vaccines, and specialized medical supplies through DLA's competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/2/25 |